大博医疗 (002901)

DOUBLE MEDICAL TECHNOLOGY INC.

ASZ

Tags

Special Purpose Equipment ManufacturingSpecial Purpose LoansMedical DevicesPharmaceuticals and HealthcareGuozheng Growth IndexSmall Cap GrowthIntelligent MachinesWest Coast of the Taiwan StraitHigh-Performing StocksShareholder ReductionMargin Trading and Securities LendingSME 300 Index

K-Line Chart

No K-line data

Stock Details

1. Key Indicators

  • Total Shares(W): 41401.95
  • Circulating A-Shares(W): 28847.64
  • Earnings Per Share(RMB): 1.0444
  • Net Assets Per Share(RMB): 8.0590
  • Operating Revenue(W RMB): 187625.48
  • Total Profit(W RMB): 51434.43
  • Net Profit Attributable to Parent(W RMB): 42464.62
  • Net Profit Growth Rate(%): 77.03
  • Weighted Return on Equity(%): 12.8300
  • Operating Cash Flow Per Share(RMB): 1.1310
  • Undistributed Profit Per Share(RMB): 4.2280
  • Capital Reserve Per Share(RMB): 2.7536

2. Main Business

The main business covers:

  • Production, R&D and sales of high-value medical consumables.

3. Company Basic Information

  • Company Name: Double Medical Technology Inc.
  • Listing Date: 2017-09-22
  • Industry: Medical and Healthcare - Medical Devices (CSRC Industry: Special Equipment Manufacturing)
  • Address: No. 18 Hongdong Road, Shanbian, Haicang District, Xiamen City, Fujian Province, China.
  • Website: www.double-medical.com
  • Company Profile: The company was established as a joint stock company by the overall change of its predecessor, Double Medical Limited, with all shareholders of Double Medical Limited, namely Double Medical Commerce, Double Medical International, and Lin Zhijun, as the promoters. On November 6, 2015, the board of directors of Double Medical Limited resolved to approve that all shareholders of Double Medical Limited jointly act as promoters, converting the audited net assets of RMB 342,704,700 as of July 31, 2015 into 320 million shares as share capital, with the remaining amount credited to capital reserve. All assets, liabilities, business, and personnel of Double Medical Limited were succeeded by the joint stock company after the change. The shareholding ratio of each promoter in the joint stock company remained unchanged from that before the overall change. On November 13, 2015, the Xiamen Municipal Bureau of Commerce issued the "Approval from Xiamen Municipal Bureau of Commerce on Agreeing to Change Xiamen Double Medical Yingjing Medical Device Co., Ltd. to a Foreign-invested Joint Stock Company" (Xia Shang Wu Shen [2015] No. 694), approving the overall change of Double Medical Limited to a foreign-invested joint stock company. On the same day, the Xiamen Municipal People's Government reissued the "Approval Certificate for Foreign-invested Enterprises of the People's Republic of China" (Shang Wai Zi Xia Wai Zi Zi [2008] No. 0113) to the company. On November 18, 2015, Tianjian issued the "Capital Verification Report" (Tian Jian Yan [2015] No. 463), verifying that the company's registered capital had been fully paid. On November 27, 2015, the Xiamen Municipal Administration for Market Regulation issued the "Business License" (Unified Social Credit Code: 913502007617290664) to the joint stock company.

4. Top 10 Circulating Shareholders

Rank Institution Name Institution Type Shares Held (W) Percentage Held (%)
1 Guangxi Double Medical Commerce Venture Capital Co., Ltd. General Legal Person 9712.41 33.66
2 Double Medical International Investment Co., Ltd. General Legal Person 8292.69 28.74
3 Hong Kong Securities Clearing Company Ltd. Northbound Capital 1245.63 4.32
4 Bosera Healthcare Industry Hybrid Securities Investment Fund Class A Fund 183.66 0.64
5 China Southern China Securities 1000 Exchange Traded Open-End Index Securities Investment Fund Fund 75.69 0.26
6 China Merchants Core Preferred Stock Securities Investment Fund Class A Fund 25.00 0.09
7 Bosera Healthy Growth Theme Bi-weekly Regular Redeemable Hybrid Securities Investment Fund Class A Fund 20.71 0.07
8 Dacheng Quality Healthcare Stock Securities Investment Fund Class A Fund 15.76 0.05
9 Bosera Healthy Life Hybrid Securities Investment Fund Class A Fund 9.78 0.03
10 CITIC-Prudential Huize 18-Month Regular Open Bond Securities Investment Fund Class A Fund 1.00 0.00

5. Concept Sectors

  • West Coast of the Taiwan Strait
  • Intelligent Machines
  • Margin Trading & Securities Lending
  • High-Performance Stocks
  • Shareholder Reduction
  • Special Loans
  • Small Cap Growth
  • SZSE Growth Index
  • SME 300 Index

Remarks

  • Data update date: 2026-01-01
  • Data source: Public Market Information